Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
May 26, 2023 16:05 ET
|
Biodexa Pharmaceuticals PLC
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a...
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
May 24, 2023 08:40 ET
|
Biodexa Pharmaceuticals PLC
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH...
Posting of Annual Report & Notice of AGM
May 22, 2023 16:15 ET
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company...
Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
May 18, 2023 08:30 ET
|
Biodexa Pharmaceuticals PLC
18 May 2023 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the...
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
May 11, 2023 10:20 ET
|
Cellectis Inc.
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Monthly information on share capital and company voting rights
May 10, 2023 16:30 ET
|
Cellectis Inc.
NEW YORK, May 10, 2023 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting...
The Acquired Aplastic Anemia Market is Projected To Reach USD 10.25 billion By 2030, From USD 7.27 billion in 2022,Registering a CAGR Of 4.20% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 08, 2023 13:20 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 08, 2023 (GLOBE NEWSWIRE) -- The Global Acquired Aplastic Anemia Market size was valued at USD 7.27 billion in 2022 and is projected to reach USD 10.25 billion by 2030, growing at a...
Biopharmaceutical Excipient Manufacturing Market Grow at a CAGR of 9.7% from 2023 to 2031 | Latest InsightAce Report
May 05, 2023 07:07 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, May 05, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the Global Biopharmaceutical Excipient Manufacturing Market- by...
Preliminary Results for the Year Ended 31 December 2022
April 28, 2023 16:30 ET
|
Biodexa Pharmaceuticals PLC
28 April 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2022 Biodexa Pharmaceuticals...
Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023
April 27, 2023 16:30 ET
|
Cellectis Inc.
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop...